Canada Pharmacies Link Blood Clots with IBD

Experts say that after operation, individuals with inflammatory bowel disease (IBD) could be of higher threat of blood clots identified as deep vein thromboses and pulmonary embolisms.  In connection, they consume additional generic Prilosec to alleviate such illnesses. 

"An increased risk of Deep vein thrombosis (DVT)  and pulmonary embolisms (PE) in patients with IBD has been evident for the past 75 years," according to co-authors Dr. Andrea Merrill of Massachusetts General Hospital and Dr. Frederick Millham of Newton-Wellesley Hospital, both in Boston. 

However, they added that "most work in this area has not looked specifically at patients undergoing surgery. Because surgery is common for people with IBD, getting a better idea of their level of risk for these clots is important."  Patients themselves must not erroneously diagnose their illness as a simple indigestion and automatically buy Prilosec. 

According to the American College of Family Physicians, "over 600,000 Americans suffer from IBD, which involves a chronic inflammation of the intestines. Crohn's disease and ulcerative colitis are two common forms of IBD." 

The study researchers finalized that "patients with IBD who undergo surgery have a twofold increased risk of DVT or PE. In patients with IBD who are having nonintestinal surgery, this risk may be even higher. These findings suggest that standard DVT and PE prophylaxis prevention should be reconsidered for this patient group." 

"Current guidelines do not recommend routine DVT and PE prophylaxis in patients with IBD undergoing surgery," said Dr. David Bernstein, chief of the division of gastroenterology at North Shore University Hospital in Manhasset, N.Y. 

However, he stated that "the data presented in this study begs the question that perhaps the approach to prevention of DVT and PE in IBD patients undergoing routine, non-emergent surgery needs to be reassessed."  Somehow, Canada pharmacies could help. 

blood clot, is the final product of the blood coagulation step in hemostasis. It is achieved via the aggregation of platelets that form a platelet plug, and the activation of the humoral coagulation system (i.e. clotting factors). A thrombus is normal in cases of injury, but pathologic in instances of thrombosis. 

Mural thrombi are thrombi adherent to the vessel wall. They are not occlusive and affect large vessels, such as heart and aorta. Grossly they appear grey-red with alternating light and dark lines (lines of Zahn) which represent bands of fibrin (lighter) with entrapped white blood cells and red blood cells (darker). 

Specifically, a thrombus is the inappropriate activation of the hemostatic process in an uninjured or slightly injured vessel. A thrombus in a large blood vessel will decrease blood flow through that vessel (termed a mural thrombus). In a small blood vessel, blood flow may be completely cut-off (termed an occlusive thrombus) resulting in death of tissue supplied by that vessel. If a thrombus dislodges and becomes free-floating, it is termed as an embolus. 

Some of the conditions which elevate risk of blood clots developing include atrial fibrillation (a form of cardiac arrhythmia), heart valve replacement, a recent heart attack (also known as a myocardial infarction), extended periods of inactivity (see deep venous thrombosis), and genetic or disease-related deficiencies in the blood's clotting abilities.